SAM
Simplify Asset Management Portfolio holdings
AUM
$1.65B
This Quarter Return
+7%
1 Year Return
+8.73%
3 Year Return
+37.73%
5 Year Return
–
10 Year Return
–
AUM
$1.04B
AUM Growth
+$1.04B
(+62%)
Cap. Flow
+$346M
Cap. Flow
% of AUM
33.12%
Top 10 Holdings %
Top 10 Hldgs %
81.33%
Holding
138
New
25
Increased
32
Reduced
16
Closed
30
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$202M |
| 2 |
Simplify Stable Income ETF
BUCK
|
$52.9M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
$50M |
| 4 |
Intuitive Surgical
ISRG
|
$10.7M |
| 5 |
Sarepta Therapeutics
SRPT
|
$8.65M |
Top Sells
| 1 |
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
|
$11.2M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$9.8M |
| 3 |
iShares MBS ETF
MBB
|
$5.38M |
| 4 |
Crinetics Pharmaceuticals
CRNX
|
$4.09M |
| 5 |
Masimo
MASI
|
$3.98M |
Sector Composition
| 1 | Healthcare | 18.76% |
| 2 | Energy | 2.4% |
| 3 | Industrials | 0.84% |
| 4 | Technology | 0.49% |
| 5 | Real Estate | 0.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares Core S&P 500 ETF
IVV
$662B
| $520M | 30.96% | 989,480 +384,653 | +64% | +$202M |
|
2
Simplify Aggregate Bond ETF
AGGH
$319M
| $105M | 6.25% | 4,896,741 -63,324 | -1% | -$1.36M |
|
|
3
Simplify Stable Income ETF
BUCK
$348M
| $79.7M | 4.74% | 3,179,679 +2,110,309 | +197% | +$52.9M |
|
|
4
iShares Core US Aggregate Bond ETF
AGG
$131B
| $57.9M | 3.45% | 591,018 +510,618 | +635% | +$50M |
|
5
Plains GP Holdings
PAGP
$3.82B
| $25M | 1.49% | 1,372,360 | – | – |
|
6
Applied Therapeutics
APLT
$71M
| $19.2M | 1.14% | 2,817,505 +400,000 | +17% | +$2.72M |
|
|
7
Intuitive Surgical
ISRG
$170B
| $12.9M | 0.77% | 32,348 +26,881 | +492% | +$10.7M |
|
|
8
Sarepta Therapeutics
SRPT
$1.78B
| $11.7M | 0.7% | 90,523 +66,808 | +282% | +$8.65M |
|
9
Cigna
CI
$80.3B
| $8.82M | 0.53% | 24,287 +12,603 | +108% | +$4.58M |
|
10
TScan Therapeutics
TCRX
$102M
| $8.31M | 0.49% | 1,046,916 | – | – |
|
|
EQLS
11
DELISTED
Simplify Market Neutral Equity Long/Short ETF
EQLS
| $6.7M | 0.4% | +287,000 | New | +$6.7M |
|
12
PureCycle Technologies
PCT
$2.57B
| $6.62M | 0.39% | 1,064,440 +733,281 | +221% | +$4.56M |
|
13
Fulcrum Therapeutics
FULC
$351M
| $6.38M | 0.38% | 676,031 +112,706 | +20% | +$1.06M |
|
14
Cooper Companies
COO
$13.4B
| $6.33M | 0.38% | 62,398 +61,702 | +8,865% | +$6.26M |
|
15
Align Technology
ALGN
$10.3B
| $6.31M | 0.38% | 19,251 +15,233 | +379% | +$5M |
|
16
Merck
MRK
$210B
| $6.29M | 0.37% | 47,663 +25,474 | +115% | +$3.36M |
|
17
Eli Lilly
LLY
$657B
| $6.26M | 0.37% | 8,041 +3,892 | +94% | +$3.03M |
|
18
Madrigal Pharmaceuticals
MDGL
$9.76B
| $6.22M | 0.37% | 23,294 +9,000 | +63% | +$2.4M |
|
19
Akero Therapeutics
AKRO
$3.74B
| $6.21M | 0.37% | 245,676 +185,899 | +311% | +$4.7M |
|
20
Phathom Pharmaceuticals
PHAT
$864M
| $5.54M | 0.33% | 521,935 +284,000 | +119% | +$3.02M |
|
|
SWAV
21
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $4.87M | 0.29% | 14,945 +10,699 | +252% | +$3.48M |
|
22
Thermo Fisher Scientific
TMO
$186B
| $4.81M | 0.29% | 8,271 +3,374 | +69% | +$1.96M |
|
23
Royalty Pharma
RPRX
$15.6B
| $4.51M | 0.27% | +148,455 | New | +$4.51M |
|
24
Exact Sciences
EXAS
$8.98B
| $4.42M | 0.26% | 64,027 +55,046 | +613% | +$3.8M |
|
25
Boston Scientific
BSX
$156B
| $4.28M | 0.25% | 62,458 +33,370 | +115% | +$2.29M |
|